Crizotinib (PF-02341066) is a potent, orally bioavailable, ATP-competitive small-molecule inhibitor of c-Met kinase and ALK (anaplastic lymphoma kinase) with IC50 values to be 4 and 25 nM for C-Met and ALK resepectively.
Molecular Weight:
450.34
Purity:
99.89%
CAS Number:
[877399-52-5]
Formula:
C21H22Cl2FN5O
Target:
c-Met
* VAT and and shipping costs not included. Errors and price changes excepted